Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide-sensitive guanylyl cyclase: structure and regulation.

Doris Koesling1, Michael Russwurm, Evanthia Mergia

  • 1Institut für Pharmakologie und Toxikologie, Medizinische Fakultät MA N1, Ruhr-Universität Bochum, 44780 Bochum, Germany. doris.koesling@ruhr-uni-bochum.de

Neurochemistry International
|August 18, 2004
PubMed
Summary

NO-sensitive guanylyl cyclase (GC) is crucial for vascular and neural signaling. New findings reveal its alpha2beta1 isoform associates with PSD-95, positioning it near nitric oxide (NO) sources for localized signaling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbon dioxide is a triple vasodilator.

Cardiovascular research·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors.

British journal of pharmacology·2025
Same author

Cardiomyocyte GC1 Mediates Estrogenic Angiogenesis in Right Heart Remodeling.

Circulation research·2025
Same author

Unsaturated fatty acids identified as reversible soluble guanylyl cyclase inhibitors.

Nitric oxide : biology and chemistry·2025
Same author

The 11th International Conference on cGMP 2024: recent trends and developments in cGMP research -meeting report.

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

Analysis of cellular NO-GC expression in the murine heart and lineage determination in angiotensin II-induced fibrosis.

iScience·2025

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • NO-sensitive guanylyl cyclase (GC) is central to the NO/cGMP signaling pathway, regulating vascular tone and neurotransmission.
  • The enzyme's activity is modulated by nitric oxide (NO) binding to its heme prosthetic group, leading to significant activation.
  • Two isoforms, alpha1beta1 and alpha2beta1, exist and were previously thought to be cytosolic.

Purpose of the Study:

  • To investigate the localization and regulatory mechanisms of NO-sensitive guanylyl cyclase isoforms.
  • To explore the interaction of GC isoforms with cellular structures and signaling partners.
  • To elucidate the physiological relevance of isoform-specific localization in NO signaling.

Main Methods:

  • The study likely involved biochemical assays to measure enzyme activity and NO binding.

Related Experiment Videos

  • Immunoprecipitation and co-localization studies were probably used to investigate protein interactions.
  • Analysis of isoform distribution in different tissues and cellular compartments was likely performed.

    • Main Results:

    • The alpha2beta1 isoform of NO-sensitive GC interacts with the post-synaptic density protein 95 (PSD-95) via its alpha2-subunit.
    • This interaction anchors the alpha2beta1 isoform to the cell membrane, specifically near PSD-95.
    • This membrane association places the enzyme in proximity to NO-generating enzymes, facilitating localized NO/cGMP signaling.

    Conclusions:

    • The alpha2beta1 isoform's interaction with PSD-95 represents a novel regulatory mechanism for NO-sensitive GC.
    • This localization suggests a specialized role for the alpha2beta1 isoform in neuronal NO signaling pathways.
    • The findings highlight distinct physiological roles for different GC isoforms, linked to their specific cellular localization and interactions.